- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2025. Philstar Global Corp. All Rights Reserved
X
+ Follow DR. GERRY TAN Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1312532 [Title] => Managing diabetes [Summary] =>The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [1] => Array ( [ArticleID] => 378942 [Title] => Landmark diabetes trial seen to control blood sugar better [Summary] => You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00 [ColumnID] => 133560 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [2] => Array ( [ArticleID] => 375197 [Title] => Drug found to delay type 2 diabetes [Summary] => Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Cebu News [SectionUrl] => cebu-news [URL] => ) ) )
DR. GERRY TAN
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1312532 [Title] => Managing diabetes [Summary] =>The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [1] => Array ( [ArticleID] => 378942 [Title] => Landmark diabetes trial seen to control blood sugar better [Summary] => You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00 [ColumnID] => 133560 [Focus] => 0 [AuthorID] => 1489320 [AuthorName] => Maria Eleanor E. Valeros [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [2] => Array ( [ArticleID] => 375197 [Title] => Drug found to delay type 2 diabetes [Summary] => Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Cebu News [SectionUrl] => cebu-news [URL] => ) ) )
abtest
By Maria Eleanor E. Valeros | April 14, 2014 - 12:00am
By Maria Eleanor E. Valeros | January 8, 2007 - 12:00am
December 15, 2006 - 12:00am
Recommended
Vice President Sara Duterte and former president Rodrigo Roa Duterte have been ousted from the National Security Council, the Philippines’ highest policy making body advising the chief executive of the land, President Ferdinand “Bongbong” Romualdez Marcos Jr., on matters of national security.
18 hours ago
The country’s security sector remains intact following President Ferdinand Marcos Jr.’s decision to reorganize the National Security Council.
23 hours ago
After a powerless end to 2024, Meralco started the New Year on the strongest possible terms.
1 day ago
Defending champion Rianne Malixi started hot but limped at the finish to settle for an even 73 in the third round of the Australian Master of the Amateurs yesterday in Victoria, Australia.
1 day ago
Alex Eala has drawn a familiar foe in Jana Fett of Croatia for the opening round of the 2025 Australian Open qualifiers at the Melbourne Park.
1 day ago
Lotto Jan 6, 2025
EZ2/LVM - 16 2
SUERTRES - 6 8 1
4D LOTTO - 0 5 6 5
6/45 Mega Lotto - 37 23 5 6 34 43
P8,910,000.00
Grand Lotto - 38 27 21 23 11 10
P29,700,000.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66